Sectors
NDRA
ENDRA Life Sciences Inc.
4.81
2 x 4.10
2 x 6.88
bid
ask
-
0.20
3.90%
10:19 AM
timesize
| Ytd | 6.18% | |
| 1y | 17.60% |
4.81
day range
5.00
2.96
52 week range
9.85
| Open | 5.00 | Prev Close | 5.00 | Low | 4.81 | High | 5.00 | Mkt Cap | 7.21M |
| Vol | 662.00 | Avg Vol | 30.63K | EPS | -6.29 | P/E | N/A | Forward P/E | -0.02 |
| Beta | -0.05 | Short Ratio | 0.05 | Inst. Own | 0.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 4.89 | 200-d Avg | 4.77 | 1yr Est | 2625.00 |
| Income Statement | |||
| Operating Expenses | 1.48M | ||
| Research and Development Expense | 233.67K | ||
| Selling, General and Administrative Expense | 1.25M | ||
| Operating Income | -1.48M | ||
| Net Income | 159.94K | ||
| Net Income Common Stock | 159.94K | ||
| Net Income Common Stock (USD) | 159.94K | ||
| Consolidated Income | 159.94K | ||
| Earnings per Basic Share | 0.12 | ||
| Earnings per Basic Share (USD) | 0.12 | ||
| Earnings per Diluted Share | 0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 159.94K | ||
| Earning Before Interest & Taxes (USD) | 159.94K | ||
| Weighted Average Shares | 1.32M | ||
| Weighted Average Shares Diluted | 2.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.54M | ||
| Cash and Equivalents (USD) | 5.54M | ||
| Investments | 1.90M | ||
| Investments Non-Current | 1.90M | ||
| Current Assets | 5.59M | ||
| Property, Plant & Equipment Net | 444.26K | ||
| Total Assets | 7.94M | ||
| Debt Current | 138.64K | ||
| Total Debt | 984.58K | ||
| Current Liabilities | 786.58K | ||
| Debt Non-Current | 845.94K | ||
| Total Liabilities | 1.63M | ||
| Accumulated Retained Earnings (Deficit) | -111.62M | ||
| Shareholders Equity | 6.31M | ||
| Shareholders Equity (USD) | 6.31M | ||
| Assets Non-Current | 2.36M | ||
| Total Debt (USD) | 984.58K | ||
| Liabilities Non-Current | 845.94K | ||
| Trade and Non-Trade Payables | 647.93K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.17K | ||
| Net Cash Flow from Financing | 3.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.18M | ||
| Capital Expenditure | -18.67K | ||
| Issuance (Purchase) of Equity Shares | 3.89M | ||
| Net Cash Flow from Investing | 2.22M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.24M | ||
| Net Cash Flow from Operations | -927.56K | ||
| Share Based Compensation | 541.90K | ||